Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a partnership with Nvidia to build a foundation model for clinical conversations and secured a strategic investment from Eli Lilly to boost evidence‑based care. The AI scribe provider now serves more than 300 health systems and is extending its platform to integrate with payers.
Also developing:
By the numbers: Kardigan targets $1.4B valuation in US IPO
Combating Antibacterial Resistant Diseases with Lasers
Researchers led by Texas A&M’s Dr. Vanderlei Bagnato are developing laser‑based, light‑activated therapies to combat antibiotic‑resistant infections. The method uses a safe photoreactive compound that, when activated by infrared light, disrupts bacterial defenses, allowing conventional antibiotics to work at normal doses. Early applications include a lollipop for resistant throat infections and an inhalable aerosol for pneumonia. Bagnato, a physicist‑turned‑biomedical engineer with over 40 companies and multiple academy memberships, aims to lower the minimum inhibitory concentration and revive existing drugs.
Clinician Startups Fail Because Product, Not Sales, Misses Market
When Clinician Entrepreneurs can’t get adoption, the Number 1 mistake is to think: “It’s not a product problem, it’s a sales problem.” Sorry but 99% of the time it IS a product problem. I’ve seen it over qnd over again from...
The Hidden Cost of Medical Board Regulation and Prosecutorial Overreach
The article argues that stringent opioid prescribing guidelines, aggressive DEA oversight, and state medical board prosecutions have created a hidden cost to the U.S. health‑care system. These regulatory and prosecutorial practices restrict legitimate pain management, drive physicians toward defensive medicine,...
Doctor‑Led Online Weight Management – Limited Slots Open
For Malaysians, wherever you are in Malaysia. 💚⚖️ Doctor-led, structured, medical weight management, fully online. We’re opening a limited number of first patient slots for our starting launch phase. 🔑 Welcome offer access closes soon. www.getmyreset.com Important: Prescription treatments are provided only after doctor...
Adolescent Depression Subtypes Show Distinct Brain Dynamics
A new Nature Communications study reveals two neurobiologically distinct subtypes of adolescent major depressive disorder by analyzing information dynamics in sensory‑association cortices. One subtype shows heightened feedforward signaling, correlating with sensory hypersensitivity and anxiety, while the other exhibits reduced feedback...
Earn Free ANCC Credits While Exploring Nursing Innovation
Learn more about #nursing and healthcare innovation through our See You Now podcast designed specifically for nurses. Stream to earn 4 free ANCC Credit Hours per bundle. https://t.co/bDFxS8h9cx Bundle topics include: ✅ Advocacy to Activism ✅ Nurses Inspiring Nurses...
Engineered Nanoparticles Could Deliver Better Targeted Cancer Treatment to Lymph Nodes
Scientists at McGill University and the Goodman Cancer Institute have engineered nanoparticles that deliver an existing immunotherapy directly to metastatic lymph nodes. The nanocomplex senses a molecule abundant in cancer‑laden nodes, activating the drug only at the disease site while...
Most Health System Innovations Die Before Scaling
Many accuse health systems of not being willing to innovate. The truth? Lots of innovation is being explored all the time - you just don’t hear about them because most never make it to system-wide scale. For every 100 ideas that...
Weekly BioTech Roundup: Top Posts Curated by BiopharmIQ
Here is my favourite weekly 🧵- made by my dear friend @BiopharmIQ - which is a comprehensive recap of the past week in BioTech. This 🧵 gathers the best BioTech posts written by some of the best & brightest 𝕏...
Safe Ultrasound Opens Brain Barrier via Tight Junctions
Researchers have detailed how focused ultrasound safely and reversibly opens the blood‑brain barrier by transiently reorganizing tight‑junction proteins. The study shows that pulsed ultrasound creates a brief paracellular window that permits therapeutic agents to reach brain tissue without causing inflammation...
Ephrin-A1–EphA2 Signaling: New Fracture Prevention Target
Researchers have identified the Ephrin‑A1/EphA2 signaling axis as a promising therapeutic target for preventing osteoporotic fractures. Preclinical studies demonstrated that blocking EphA2 activity enhances bone formation and improves microarchitecture in mouse models of age‑related bone loss. The findings suggest that...
Integrative Oncology Nutrition: A Case Study in Leukemia Recovery
A functional‑medicine physician documented a leukemia patient’s four‑week integrative nutrition program that complemented maintenance chemotherapy. The regimen emphasized time‑restricted eating, phytonutrient‑dense low‑carb foods, magnesium repletion, and personalized movement. Laboratory markers showed platelets rise 63%, hemoglobin up 7%, and red cells...
Relief Might Be Fleeting for the Healthcare Industry After Supreme Court Strikes Down Most Tariffs
The Supreme Court ruled 6‑3 that most Trump‑era tariffs imposed under the International Emergency Economic Powers Act are invalid, wiping out 25% duties on Canadian and Mexican imports and a 20% hike on China. Sector‑specific duties on steel, aluminum and...
Stories, Not Data, Drive Health Tech Adoption
We want Health Tech to be evidence-based, but the truth is that adoption is ultimately driven by stories - NOT data. Here’s what I’ve seen play out over the past 13+ years over and over again: → Health system execs will choose...
Study Lacks Equipoise: Control Babies Likely Infected
The key point here is that the proposed study would not have equipoise because almost certainly some babies in the control arm would get hepatitis from their infected mother.
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
Medtronic, one of the world’s largest medical‑device makers, is refocusing on its highest‑margin, fastest‑growing businesses by spinning off its diabetes unit. The company continues to innovate, highlighted by the Hugo surgical robot, and has delivered 48 straight annual dividend increases,...
Two Authors Shouldn't Qualify for Major Trial Abstract
Submitting an abstract for a late-stage large clinical trial for review at a major conference, where you're asking for an oral, but only having 2 authors should be disqualifying. Really, only *2* people acquired ALL the data for this? Disgraceful...
Markets Switch to AI When It Outperforms Tradition
The market doesn’t care how long you’ve done it “the old way.” If AI can do it faster, cheaper, better — the switch will happen. https://t.co/zQCFnB0Dpd
Pharmacists Navigate an Evolving Immunotherapy Landscape in Advanced Non–Small Cell Lung Cancer
Oncology pharmacists are increasingly central to advanced non‑small cell lung cancer (NSCLC) care, overseeing treatment selection, biomarker testing, and patient education. Recent data show cemiplimab improves overall survival both as monotherapy in high PD‑L1 tumors and when combined with chemotherapy...
Combined DNA and Methylation Analysis Reveals Colon Cancer Risks
By systematically assessing both DNA sequence variants and methylation, we're learning a lot more about risk of (and protection from) colon cancer @ScienceAdvances https://t.co/eA0Y0lrntr https://t.co/5iL4sg0rRC
Teclistamab‑Daratumumab Shows Strong Benefit in RRMM
Teclistamab–Daratumumab in Relapsed or Refractory Multiple Myeloma [Feb 18, 2026] @End_myeloma et al. @NEJM https://t.co/PTSmdrV2zp #mmsm #tcellrx #ImmunoOnc QUICK TAKES: New phase 3 trial results are summarized in a short video.
This Is How You Do It: Dentist Speaks Out After Practice Hit by Cyber Attack
Grange Dental Care in Northern Ireland suffered a cyber attack on Thursday morning, resulting in fraudulent invoice emails being sent from its system. The breach was identified at 9:50 am, and the dentist immediately alerted his IT provider, who halted the...
Exposure‑Response Guides Belantamab Dose in RR‑MM
Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma [Sep 1, 2021] Ferron-Brady et al. Clinical Pharmacology & Therapeutics https://t.co/58kmDFKRwO #mmsm #oncopharm #caxtx
Anti‑BCMA CAR‑T Triggers Immunoglobulin Isotype Switching
Immunoglobulin Isotype Switch after Anti-BCMA CAR T-Cell Therapy for Relapsed or Refractory Multiple Myeloma [Nov 10, 2021] Liang et al. @BloodAdvances https://t.co/KfreDCvIDH #CARTcell #mmsm https://t.co/7qNQBEoqkX
Boston Scientific’s Penumbra Acquisition: Impacts and 3D Printing Opportunities in Vascular Medicine
Boston Scientific announced a $14.5 billion acquisition of Penumbra, re‑entering the neurovascular market and expanding its cardiovascular device portfolio. The deal, paid at a 19 % premium with a 73 % cash and 27 % stock mix, targets Penumbra’s thrombectomy and embolization technologies. Boston...
Antigen Escape Drives Resistance to BCMA Therapies
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma [Jul 25, 2024] @RossFirestone et al. @BloodJournal https://t.co/cOh0YC2u9H #mmsm #ImmunoOnc #CARTcell #PrecisionMedicine #lymphoidneoplasia #immunobiologyandimmunotherapy https://t.co/6sbEv5KtLY
Sometimes Less Is More: Messier Nanoparticles May Actually Deliver Drugs More Effectively than Tightly Packed Ones
Researchers at the University of Copenhagen unveiled a high‑throughput, single‑nanoparticle analysis that examined millions of lipid nanoparticles (LNPs) used for RNA delivery. The study identified two distinct LNP subpopulations—organized, onion‑layered particles and disordered, amorphous particles—and found the latter release their...
It Seems Bad That Temu Is Selling Peptides
A recent Futurism report reveals that the low‑cost e‑commerce platform Temu is selling a variety of peptide products, including BPC‑157 and GLP‑1‑like compounds, at prices as low as $4. These peptides, marketed as muscle, skin, or cognitive boosters, are often...
GLP-1 Drugs Fail to Slow Cognitive Decline in Alzheimer’s Disease
Recent randomized trials testing GLP‑1 receptor agonists such as semaglutide and liraglutide in Alzheimer’s disease patients found no measurable slowing of cognitive decline. Earlier post‑hoc and observational analyses had suggested roughly a 50 % reduction in dementia incidence, raising hopes of...
Why Are Ultra Processed Foods So Tasty? And Why Are They So Bad For You?
Ultra‑processed foods dominate modern diets, offering convenience and engineered palatability. A recent American Journal of Medicine study of nearly 4,700 adults linked high consumption of these foods to a 47% greater risk of cardiovascular disease. Parallel research in Cell Metabolism...
Patients Prefer AI Over Frustrating Healthcare Appointment Process
the overall experience for patients from booking health related appointments to waiting ++ is so bad that they will gladly use AI first to avoid frustration
How Arintra’s Coding AI Helped Mercyhealth Boost Revenue by 5%
Mercyhealth, a 6‑hospital system serving northern Illinois and southern Wisconsin, deployed Arintra’s AI‑driven coding platform across 37 sites in 2023. The technology automates chart coding, writes medical codes directly into the EHR, and flags missed reimbursement opportunities. Since implementation, the...
From Mental Health Issues to Cancer Care: AI Startups Reimagine Healthcare Access with Smart Diagnostics, Digital Tools, Tele-Doctors
At the AI Impact Summit in New Delhi, several startups unveiled AI‑driven solutions aimed at widening healthcare access. Clinics on Cloud introduced “Health ATMs” that combine on‑site screenings for 60+ conditions with tele‑doctor consults, claiming 90‑95% laboratory‑grade accuracy. Other launches...
State Bill to Standardize Nursing Home Admission Contracts, Limit Role of ‘Assistors’
New Jersey lawmakers introduced a bill requiring the Department of Health to create uniform admission contracts for nursing homes and assisted‑living facilities and to restrict Medicaid "assistors" from providing legal or financial guidance. The legislation also mandates clear notification of...
6 Lessons Shaping Health System Strategic Leaders’ Operational Approach for 2026
Health system leaders are reshaping 2026 operations amid technology, regulation, and labor pressures. Executives from Cedars‑Sinai to Novant Health stress frontline immersion, cost‑control focus, system‑design that simplifies right actions, and building trust through candid dialogue. Prioritizing a narrow set of...
TyG-BMI Can Help Predict In-Hospital Mortality in HFmrEF With Hypertension
A recent study published in Lipids in Health and Disease shows that the triglyceride‑glucose‑body‑mass‑index (TyG‑BMI) markedly improves prediction of in‑hospital mortality among hypertensive patients with heart failure with mildly reduced ejection fraction (HFmrEF). In a cohort of 2,550 admissions, each...
Eli Lilly Invests $3.5B in Pennsylvania to Scale Next‑Gen Obesity Drug Manufacturing
Eli Lilly announced a $3.5 billion investment to build a new injectable‑medicine plant in Lehigh Valley, Pennsylvania. The facility, slated to break ground in 2026 and run by 2031, will focus on next‑generation obesity and metabolic drugs such as the triple‑agonist retatrutide....
Learning From FDA’s Moderna U-Turn
The FDA abruptly reversed its decision to approve Moderna’s mRNA‑based flu vaccine after the White House intervened, sparking intense discussion in biotech boardrooms. The reversal was driven by political considerations rather than new scientific data, underscoring the agency’s vulnerability to...
Clinical AI Offers Hope: More Impact, Less Complexity
"This is the first time where there's hope - there is a pathway to doing more with less. There is a pathway for the job of being a clinician, being a nurse, to be a fulfilling one. There is a...
Navigating the Expanding MS Treatment Landscape: Kavita Nair, PhD
The multiple sclerosis (MS) treatment landscape has exploded from four to 23 disease‑modifying therapies, giving clinicians a broad menu of oral, injectable, infusion, generic, and biosimilar options. Selecting a therapy now hinges on balancing efficacy and safety with real‑world factors...
Novartis Breaks Ground on $23B Biomedical Research Hub in San Diego
Novartis began construction of a new biomedical research hub in San Diego. The 466,000‑sq‑ft center, part of a $23 billion US R&D and manufacturing program, will house about 1,000 researchers and target neuroscience, oncology, global health, and age‑related diseases. Scheduled to...
Croom Medical Breaks Ground on R&D Site in Ireland
Croom Medical has broken ground on ACOT, a 38,000‑square‑foot Advanced Centre of Orthopaedic Technologies in Croom, County Limerick. The project represents the company’s largest capital outlay in its 42‑year history and will serve as a combined R&D and industrialisation hub....
WestFax Launches AI-Powered Intelligent Document Processing Platform for Healthcare
WestFax launched Comprehend, an AI‑powered Intelligent Document Processing platform for healthcare, now available across all its service tiers. The solution uses OCR, AI and FHIR‑aligned models to convert inbound fax, email and file‑based documents into searchable PDFs, classify types, and...
How to Avoid a Fall by Balancing Cost and Performance in Drug Discovery
Balancing cost and performance in drug discovery requires a hybrid engineering‑led approach that combines on‑premise HPC with scalable cloud resources. Uncontrolled cloud scaling can drive unpredictable expenses, while pure on‑premise systems demand high upfront capital and maintenance. By implementing disciplined...
DOJ and Ohio AG Charge OhioHealth with Price‑Gouging, Anti‑Competition
DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition https://t.co/oxxD0glykV via @statnews
Elevance Health's Value-Based Care Models Deliver Measurable Quality Gains: Kristie Spencer
Elevance Health reported that 60.5% of its medical spend now flows through value‑based care contracts, with shared‑risk arrangements climbing to 37%—a 4‑point rise from the previous year. The company’s 2024 Advancing Health Together report shows that 76% of its value‑based...
Wet, Dry AMD Require Different Methods of Treatment, Including Anti-VEGF: Julie Rosenthal, MD, MS
Age‑related macular degeneration (AMD) affects roughly 19.8 million Americans and remains a leading cause of blindness. The disease is split into dry and wet forms, each requiring distinct therapeutic approaches. Wet AMD is managed with intravitreal anti‑VEGF injections, with newer agents...
CDC Enterprise Architect to Detail Digital Transformation at HIMSS26
At HIMSS26, CDC Acting Chief Enterprise Architect Ryan M. Harrison will unveil the agency’s Technical Reference Architecture (TRA), a unified framework that codifies IT standards across CDC. The presentation targets both IT leaders and developers, illustrating how the TRA integrates...
Altesa BioSciences Raises $75M Series B
Altesa BioSciences announced an oversubscribed $75 million Series B round, led by Forbion with participation from Sanofi and existing backers Medicxi, Pitango, and Atlantic Partners. The financing will support the development of its lead candidate, vapendavir, targeting viral-driven exacerbations in COPD and...
Topical Adquey (Difamilast) Wins FDA Approval for Atopic Dermatitis
The U.S. Food and Drug Administration has granted approval to Adquey, a 1% difamilast topical ointment, for the treatment of mild-to-moderate atopic dermatitis in patients two years and older. Developed by Otsuka and licensed to Acrotech Biopharma, the product is...